Warning letter
Essential Pharmacy Compounding: warning letter of Mar 10, 2016
FDA warning letter 489638 · Kansas City District Office
Key facts
| Reference number | 489638 |
|---|---|
| Company | Essential Pharmacy Compounding |
| Subject | CGMP/Compounded Drugs/Adulterated |
| Issue date | Mar 10, 2016 |
| Posted date | Apr 22, 2016 |
| Issuing office | Kansas City District Office |
| Product type | Drugs |
| Inspection city | Omaha |
| Inspection ZIP | 68154-1571 |
| Inspection start date | May 12, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: